A Study of LY3015014 in Healthy Participants With Elevated Low Density Lipoprotein Cholesterol

Summary

This is a study in otherwise healthy Japanese and non-Japanese participants with elevated low density lipoprotein cholesterol (LDL-C). Following single doses of LY3015014, the safety and tolerability of the drug, how the body handles the drug, and the drug's effect on the body will be evaluated. Participants will remain in the study for approximately up to 6 months.

Timeline

Start

2011-09

Primary completion

2013-06

Completion

2013-06

Drugs

Indications